These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2014459)

  • 1. Epidemiological reference ranges for low-density lipoprotein cholesterol and apolipoprotein B for identification of increased risk of ischaemic heart disease.
    Vermaak WJ; Kotze JP; van der Merwe AM; Becker PJ; Ubbink JB; Barnard HC; Roux FG; Schoeman JJ; Strydom GL
    S Afr Med J; 1991 Apr; 79(7):367-71. PubMed ID: 2014459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action limits for serum total cholesterol. A statement for the medical profession by an ad hoc committee of the Heart Foundation of Southern Africa.
    Rossouw JE; Steyn K; Berger GM; Vermaak WJ; Kock J; Seftel HC; Gevers W
    S Afr Med J; 1988 Jun; 73(12):693-700. PubMed ID: 3381151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
    St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
    Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population.
    Martinez-Hervas S; Real JT; Priego MA; Carratalá A; Sniderman AD; Carmena R; Ascaso JF
    Int J Clin Pract; 2013 Jan; 67(1):81-8. PubMed ID: 23241052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
    Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
    Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
    Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
    Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage and segregation analyses of apolipoproteins A1 and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study.
    Amos CI; Elston RC; Srinivasan SR; Wilson AF; Cresanta JL; Ward LJ; Berenson GS
    Genet Epidemiol; 1987; 4(2):115-28. PubMed ID: 3108069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males].
    Olszewski R; Grabysa R; Warmiński J; Makowski T; Szczechowicz R; Piechota W; Adamus J
    Pol Merkur Lekarski; 2002 Jul; 13(73):14-7. PubMed ID: 12362497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project.
    Gardner CD; Tribble DL; Young DR; Ahn D; Fortmann SP
    Prev Med; 2000 Oct; 31(4):346-56. PubMed ID: 11006059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation of apolipoproteins A-I and B in children to parental myocardial infarction.
    Freedman DS; Srinivasan SR; Shear CL; Franklin FA; Webber LS; Berenson GS
    N Engl J Med; 1986 Sep; 315(12):721-6. PubMed ID: 3092050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipids and apolipoproteins in relation to the degree of coronary sclerosis].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Abe I; Strauss HJ; Schmidt H; Schaedel H; Reuter W
    Z Gesamte Inn Med; 1986 Feb; 41(4):98-102. PubMed ID: 3705656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What is a good marker for serum cholesterol to identify high-risk patients at general health checks?].
    Fujioka Y
    Rinsho Byori; 2012 Apr; 60(4):328-35. PubMed ID: 22686042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.